These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6312702)

  • 1. [Biological effects of coordination compounds of transitional metals. The beta-lactamase inhibitory effect of cis-platin, 2-aminopyridine palladium chloride, clavulanic acid and penicillanic acid sulfonate CP 45,899 in the nitrocefin test and Titertek/microtiter automatic system].
    Fleck WF; Heyn B; Schröer HP
    Z Allg Mikrobiol; 1983; 23(5):313-7. PubMed ID: 6312702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-lactamase inhibition by acetylmethylene penicillanic acid compared to that of clavulanate and sulbactam.
    Chin NX; McElrath MJ; Neu HC
    Chemotherapy; 1988; 34(4):318-25. PubMed ID: 2850139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of beta-lactamase inhibitors on beta-lactamases from anaerobic bacteria.
    Hedberg M; Lindqvist L; Tunér K; Nord CE
    Eur J Clin Microbiol Infect Dis; 1992 Nov; 11(11):1100-4. PubMed ID: 1338315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The biological effects of coordination compounds of transitional metals. 6. Effect of 4-methyl-2-aminopyridine-palladium chloride and cis-dichlorodiammine-platinum(II) on retroviruses and the virus-associated RNA polymerase of the influenza virus].
    Sydow G; Wunderlich V; Baumbach L; Tonew E; Tonew M; Schröer HP
    Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Aug; 262(2):169-78. PubMed ID: 2431560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penicillanic acid sulfone: nature of irreversible inactivation of RTEM beta-lactamase from Escherichia coli.
    Brenner DG; Knowles JR
    Biochemistry; 1984 Nov; 23(24):5833-9. PubMed ID: 6098299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of beta-lactamase inhibitors.
    Rolinson GN
    Rev Infect Dis; 1991; 13 Suppl 9():S727-32. PubMed ID: 1656513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of clavulanic acid, sulbactam and tazobactam on three different beta-lactamases from Bacteroides uniformis, Clostridium butyricum and Fusobacterium nucleatum.
    Hedberg M; Lindqvist L; Tunér K; Nord CE
    J Antimicrob Chemother; 1992 Jul; 30(1):17-25. PubMed ID: 1331018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Activity of sulbactam and clavulanic acid, alone and combined, on Acinetobacter calcoaceticus].
    Kitzis MD; Goldstein FW; Labia R; Acar JF
    Ann Microbiol (Paris); 1983; 134A(2):163-8. PubMed ID: 6307103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 6-(Methoxymethylene)penicillanic acid: inactivator of RTEM beta-lactamase from Escherichia coli.
    Brenner DG; Knowles JR
    Biochemistry; 1984 Nov; 23(24):5839-46. PubMed ID: 6098300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of the effect of beta-lactamase inhibitors on the beta-lactamase in growing cultures of gram-negative bacteria with their effect on the isolated beta-lactamase.
    Easton CJ; Knowles JR
    Antimicrob Agents Chemother; 1984 Sep; 26(3):358-63. PubMed ID: 6095753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of clavulanic acid, sulbactam and cephamycin antibiotics with beta-lactamases.
    Grace ME; Fu KP; Gregory FJ; Hung PP
    Drugs Exp Clin Res; 1987; 13(3):145-8. PubMed ID: 3040368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrophotometric determination of inhibitory effects of CP-45899 on beta-lactamase with benzylpenicillin and nitrocefin.
    Yamabe S
    J Antimicrob Chemother; 1980 May; 6(3):420-1. PubMed ID: 6249784
    [No Abstract]   [Full Text] [Related]  

  • 13. Activity of beta-lactamase inhibitors in combination with new beta-lactam antibiotics against resistant gram-negative organisms.
    Bolivar R; Weaver SS; Bodey GP
    Diagn Microbiol Infect Dis; 1984 Jun; 2(3):255-60. PubMed ID: 6086213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-lactamase inhibitors and Acinetobacter spp.
    Eng RH; Smith SM; Cherubin CE
    J Antimicrob Chemother; 1990 Sep; 26(3):449-51. PubMed ID: 2172200
    [No Abstract]   [Full Text] [Related]  

  • 15. Interaction of beta-lactamase inhibitors with various beta-lactamases.
    Cullmann W
    Chemotherapy; 1990; 36(3):200-8. PubMed ID: 2159863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation in the potentiation of beta-lactam antibiotic activity by clavulanic acid and sulbactam against multiply antibiotic-resistant bacteria.
    Aldridge KE; Sanders CV; Marier RL
    J Antimicrob Chemother; 1986 Apr; 17(4):463-9. PubMed ID: 3011724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fixed or variable concentrations of beta-lactamase inhibitors in in-vitro tests?
    Greenwood D
    J Antimicrob Chemother; 1996 Jul; 38(1):17-20. PubMed ID: 8858452
    [No Abstract]   [Full Text] [Related]  

  • 18. Synergy of clavulanic acid, sulbactam and tazobactam (YTR 830) with amoxycillin against fifty beta-lactamase-producing strains of Haemophilus influenzae.
    Simonet M; Moittie D; Philippon A; Descamps P; Veron M
    J Antimicrob Chemother; 1989 May; 23(5):798-800. PubMed ID: 2547748
    [No Abstract]   [Full Text] [Related]  

  • 19. In-vitro evaluation of the four beta-lactamase inhibitors: BRL42715, clavulanic acid, sulbactam, and tazobactam.
    Muratani T; Yokota E; Nakane T; Inoue E; Mitsuhashi S
    J Antimicrob Chemother; 1993 Sep; 32(3):421-9. PubMed ID: 8262864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of four beta-lactamase inhibitors in combination with ampicillin against Mycobacterium tuberculosis.
    Sorg TB; Cynamon MH
    J Antimicrob Chemother; 1987 Jan; 19(1):59-64. PubMed ID: 3030999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.